{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:49:25Z","timestamp":1776725365191,"version":"3.51.2"},"reference-count":20,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2014,2,28]]},"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The objective of our follow-up study is to evaluate liver function tests (LFTs) and lipid profiles in patients with Gilbert's syndrome treated with isotretinoin because of severe acne.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Dermatology outpatient clinics of three regional hospitals of Ja\u00e9n (Spain).<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Over 4\u2005years, we included all patients diagnosed with severe acne. Only 37 patients were identified, of which 11 had Gilbert's syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>All patients were treated with isotretinoin and followed-up in our outpatient clinics after 10 and 20\u2005weeks. Patients were subjected to an interview questionnaire which included data on age, gender, complete blood count, coagulation profile, fasting blood glucose, LFTs and lipid profiles. Data and results of patients with severe acne and Gilbert's syndrome were compared with those of 26 patients with only severe acne (control group).<\/jats:p><\/jats:sec><jats:sec><jats:title>Primary outcome<\/jats:title><jats:p>Blood analyses were repeated in the follow-up visits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In patients with Gilbert's syndrome, bilirubin levels showed substantial decrease over the 20-week follow-up, with more decrease after 10\u2005weeks. None of the control group patients had significant increase in total bilirubin levels after 10 and 20\u2005weeks of follow-up. Liver enzymes were maintained within normal levels in both groups. Both study groups did not show significant pathological increase in lipid profile levels. LDL levels were increased in the two study groups, but this increase was less substantial in patients with Gilbert's syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our preliminary results suggest that oral isotretinoin could be an effective, safe treatment for patients with Gilbert's syndrome, and may lower bilirubin levels in the first 10\u2005weeks of treatment. Limitations of the study include the small numbers of participants and the fact that it is restricted to one region of Spain.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2013-004441","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T03:25:41Z","timestamp":1395372341000},"page":"e004441","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatotoxicity of isotretinoin in patients with acne and Gilbert's syndrome: a comparative study"],"prefix":"10.1136","volume":"4","author":[{"given":"Pablo","family":"Fern\u00e1ndez-Crehuet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Fern\u00e1ndez-Crehuet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Farouk","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Fern\u00e1ndez-Crehuet Navajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"2024051511420093000_4.3.e004441.1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(84)90074-3"},{"key":"2024051511420093000_4.3.e004441.2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1590\/S0365-05962012000300005","article-title":"The effect of isotretinoin on triglycerides and liver aminotransferases","volume":"87","author":"Vieria","year":"2012","journal-title":"An Bras Dermatol"},{"key":"2024051511420093000_4.3.e004441.3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1590\/S0365-05962011000400033","article-title":"Adult women with acne have a higher risk of elevated triglyceride levels with the use of oral isotretinoin. [Article in English, Portuguese]","volume":"86","author":"Schmitt","year":"2011","journal-title":"An Bras Dermatol"},{"key":"2024051511420093000_4.3.e004441.4","unstructured":"Gilbert syndrome. American Liver Foundation website. http:\/\/www.liverfoundation.org\/abouttheliver\/info\/gilbertsyndrome\/ (accessed 25 Jun 2013)."},{"issue":"(4 Pt 1)","key":"2024051511420093000_4.3.e004441.5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0190-9622(84)70204-0","article-title":"Retinoids: a review","volume":"11","author":"Dicken","year":"1984","journal-title":"J Am Acad Dernatol"},{"key":"2024051511420093000_4.3.e004441.6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2133.2009.09241.x","article-title":"The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol","volume":"161","author":"Gr\u00f8nh\u00f8j Larsen","year":"2009","journal-title":"Br J Dermatol"},{"key":"2024051511420093000_4.3.e004441.7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0090-9556(25)08329-1","article-title":"Metabolism of isotretinoin. Biliary excretion of isotretinoin glucuronide in the rat","volume":"14","author":"Meloche","year":"1986","journal-title":"Drug Metab Dispos"},{"issue":"(Suppl 1)","key":"2024051511420093000_4.3.e004441.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne","volume":"26","author":"Nast","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024051511420093000_4.3.e004441.9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0190-9622(95)90216-3","article-title":"Isotretinoin-associated normalization of hyperbilirubinemia in patients with Gilbert's syndrome","volume":"32","author":"Wang","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"2024051511420093000_4.3.e004441.10","first-page":"463","article-title":"Gilbert disease and isotretinoin","volume":"124","author":"Le Gal","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"2024051511420093000_4.3.e004441.11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(70)91269-9","article-title":"Treatment of Gilbert's syndrome with phenobarbitone","volume":"1","author":"Black","year":"1970","journal-title":"Lancet"},{"key":"2024051511420093000_4.3.e004441.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb03164.x"},{"key":"2024051511420093000_4.3.e004441.13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2133.1991.tb00598.x","article-title":"Isotretinoin treatment alters steroid metabolism in women with acne","volume":"124","author":"Rademaker","year":"1991","journal-title":"Br J Dermatol"},{"key":"2024051511420093000_4.3.e004441.14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198404193101605","article-title":"Vitamin A and retinoids in health and disease","volume":"310","author":"Goodman","year":"1984","journal-title":"N Engl J Med"},{"key":"2024051511420093000_4.3.e004441.15","first-page":"484","article-title":"Adverse effects of isotretinoin therapy","volume":"33","author":"Bruno","year":"1984","journal-title":"Cutis"},{"key":"2024051511420093000_4.3.e004441.16","first-page":"38","article-title":"Efficacy and adverse effects of systemic isotretinoin therapy","volume":"21","author":"Muhammad Tahir","year":"2011","journal-title":"J Pak Assoc Dermatol"},{"key":"2024051511420093000_4.3.e004441.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00601-3"},{"key":"2024051511420093000_4.3.e004441.18","doi-asserted-by":"publisher","DOI":"10.1373\/49.7.1039"},{"key":"2024051511420093000_4.3.e004441.19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/15353702-0322805-29","article-title":"Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies","volume":"228","author":"Novotny","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"2024051511420093000_4.3.e004441.20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clinbiochem.2010.12.003","article-title":"Decreased small dense LDL levels in Gilbert's syndrome","volume":"44","author":"Tapan","year":"2011","journal-title":"Clin Biochme"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2013-004441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T03:43:26Z","timestamp":1746157406000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2013-004441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,20]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1136\/bmjopen-2013-004441"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2013-004441","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}